全文获取类型
收费全文 | 2460篇 |
免费 | 277篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 65篇 |
妇产科学 | 29篇 |
基础医学 | 160篇 |
口腔科学 | 78篇 |
临床医学 | 336篇 |
内科学 | 555篇 |
皮肤病学 | 42篇 |
神经病学 | 92篇 |
特种医学 | 385篇 |
外科学 | 429篇 |
综合类 | 24篇 |
预防医学 | 317篇 |
眼科学 | 26篇 |
药学 | 84篇 |
中国医学 | 2篇 |
肿瘤学 | 126篇 |
出版年
2023年 | 53篇 |
2022年 | 23篇 |
2021年 | 28篇 |
2020年 | 44篇 |
2019年 | 28篇 |
2018年 | 64篇 |
2017年 | 39篇 |
2016年 | 50篇 |
2015年 | 66篇 |
2014年 | 114篇 |
2013年 | 147篇 |
2012年 | 81篇 |
2011年 | 85篇 |
2010年 | 85篇 |
2009年 | 98篇 |
2008年 | 94篇 |
2007年 | 117篇 |
2006年 | 92篇 |
2005年 | 79篇 |
2004年 | 77篇 |
2003年 | 61篇 |
2002年 | 47篇 |
2001年 | 58篇 |
2000年 | 46篇 |
1999年 | 54篇 |
1998年 | 75篇 |
1997年 | 93篇 |
1996年 | 84篇 |
1995年 | 64篇 |
1994年 | 67篇 |
1993年 | 55篇 |
1992年 | 30篇 |
1991年 | 31篇 |
1990年 | 47篇 |
1989年 | 56篇 |
1988年 | 39篇 |
1987年 | 45篇 |
1986年 | 46篇 |
1985年 | 41篇 |
1984年 | 20篇 |
1983年 | 19篇 |
1982年 | 28篇 |
1981年 | 34篇 |
1980年 | 26篇 |
1979年 | 16篇 |
1978年 | 14篇 |
1977年 | 18篇 |
1976年 | 18篇 |
1975年 | 13篇 |
1973年 | 9篇 |
排序方式: 共有2759条查询结果,搜索用时 31 毫秒
51.
Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer. 总被引:2,自引:0,他引:2
Nasser K Altorki Jeffrey L Port Fan Zhang Dragan Golijanin Howard T Thaler Anna J Duffield-Lillico Kotha Subbaramaiah Andrew J Dannenberg 《Clinical cancer research》2005,11(11):4191-4197
PURPOSE: To determine the effect of taxane-based chemotherapy on intratumoral levels of cyclooxygenase-2 (COX-2) and prostaglandin E(2) (PGE(2)) in patients with non-small cell lung cancer (NSCLC). EXPERIMENTAL DESIGN: Lung specimens obtained at the time of surgery were used to measure levels of COX-2 and PGE(2) in tumors and adjacent nontumorous tissues in three subsets of NSCLC patients who underwent: (A) surgical resection only (n = 16); (B) surgical resection after preoperative taxane-based chemotherapy (n = 13); or (C) surgical resection after preoperative chemotherapy coadministered with the selective COX-2 inhibitor, celecoxib 400 mg bid (n = 17). RESULTS: Levels of intratumoral PGE(2) were nearly 3-fold higher among patients who received preoperative chemotherapy compared with those treated by surgery alone (P < 0.001). This difference was abrogated by the addition of celecoxib to preoperative chemotherapy (P < 0.001). Amounts of intratumoral COX-2 were approximately 3-fold higher in groups of patients who received preoperative chemotherapy with celecoxib (P < 0.0001) or without celecoxib (P < 0.001), compared with the group who underwent surgical resection only. Importantly, statistically significant positive correlations between COX-2 and PGE(2) were observed in the surgery only (r = 0.502, P = 0.047) and preoperative chemotherapy groups (r = 0.740, P = 0.004); this correlation was abrogated when celecoxib was given with chemotherapy (r = 0.005, P = 0.98). CONCLUSIONS: Treatment with chemotherapy led to increased amounts of COX-2 and PGE(2) in NSCLC. Cotreatment with celecoxib abrogated the increase in levels of PGE(2) but not COX-2 induced by chemotherapy. Importantly, these results clearly show that levels of a pharmacologic target (i.e., COX-2) can be affected by both the intrinsic molecular properties of a tumor and therapy. 相似文献
52.
Buprenorphine is considered one of the most effective treatments for opioid use disorder and significantly reduces risk of overdose death. However, concerns about its diversion and misuse have often taken center stage in public discourse and in the design of practices and policies regarding its use. This has been to the detriment of many vulnerable patient populations, especially those involved in the criminal justice system. Policies that restrict access to buprenorphine in criminal justice and other settings due to concerns of diversion do not accurately reflect the relative risks and safety profile associated with it, creating unnecessary barriers that drive an illicit market of this much-needed medication. Although proper regulation of all controlled medications should be a priority, in most instances the benefits of buprenorphine highly outweigh its risks. In the midst of a national crisis, efforts should be focused on expanding, and not restricting, access to this lifesaving treatment. 相似文献
53.
54.
55.
56.
CJ Stewart ECL Marrs S Magorrian A Nelson C Lanyon JD Perry ND Embleton SP Cummings JE Berrington 《Acta paediatrica (Oslo, Norway : 1992)》2012,101(11):1121-1127
Aim: To describe gut colonization in preterm infants using standard culture and 16S gene rRNA profiling, exploring differences in healthy infants and those who developed NEC/late onset sepsis (LOS). Methods: Ninety‐nine stools from 38 infants of median 27‐week gestation were cultured; 44 stools from 27 infants had their microbial profiles determined by 16S. Ordination analyses explored effects of patient variables on gut communities. Results: Standard microbiological culture identified a mean of two organisms (range 0–7), DGGE 12 (range 3–18) per patient. Enterococcus faecalis and coagulase negative staphylococci (CONS) were most common by culture (40% and 39% of specimens). Meconium was not sterile. No fungi were cultured. Bacterial community structures in infants with NEC and LOS differed from healthy infants. Infants who developed NEC carried more CONS (45% vs 30%) and less Enterococcus faecalis (31% vs 57%). 16S identified Enterobacter and Staphylococcus presence associated with NEC/LOS, respectively. Conclusions: Important differences were found in the gut microbiota of preterm infants who develop NEC/LOS. The relationship of these changes to current practices in neonatal intensive care requires further exploration. 相似文献
57.
Hayat Mousa Rodrigo Machado Marina Orsi Catherine S. Chao Tala Alhajj Mark Alhajj Courtney Port Beth Skaggs Frederick W. Woodley 《Current gastroenterology reports》2014,16(8):1-8
Pancreatic cancer is the fourth leading cause of cancer deaths in the USA. Although some patients will present with premalignant pancreatic lesions (i.e., intraductal papillary mucinous neoplasms) or localized tumors amenable to curative resection, the majority of patients will unfortunately present with technically unresectable or metastatic disease. This review of the recent medical literature will discuss the optimal work-up and management of premalignant pancreatic lesions and the surgical management of localized, borderline resectable, and locally advanced (i.e., unresectable) pancreatic tumors. It will focus on new criteria used to define surgical “resectability,” the significance and clinical impact of surgical margins, the role of multimodality therapy in the management of patients with borderline resectable or locally advanced tumors, the role of surgery for local or distant recurrence, and minimally invasive surgical approaches. 相似文献
58.
59.
A diaper bank and home visiting partnership: Initial exploration of research and policy questions
下载免费PDF全文
![点击此处可从《Public health nursing (Boston, Mass.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
60.
E.R. Port 《Breast Diseases: A Year Book Quarterly》2013,24(4):364-365